Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02477930 · ClinicalTrials.gov registry record
Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 65
- Enrollment target
NCT02477930 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 65 participants.
The verdict
NCT02477930 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.
Interventions
- OTHER No interventions are done
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-11-01 |
| Est. Completion | 2023-09-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02477930
The ClinicalTrials.gov registry entry for NCT02477930 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No interventions are done is the first listed.
NCT02477930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02477930 about?
NCT02477930 is a clinical study titled "Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations". The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.
What is the current status of trial NCT02477930?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2014-11-01. Estimated completion is 2023-09-21.
What interventions are being tested in trial NCT02477930?
The interventions under investigation include: No interventions are done (OTHER).
Who is sponsoring clinical trial NCT02477930?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.